{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:32:34Z","timestamp":1772789554702,"version":"3.50.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"972","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Tibolone is a relatively new drug for postmenopausal women, which is structurally related to 19-nortestosterone derivatives and exhibits weak oestrogenic, progestogenic and androgenic activities. The effect of tibolone on breast tissue is still obscure. In vitro studies have shown conflicting results regarding the effects of tibolone on breast cells. On the other hand, although epidemiological studies show an increase in the risk of breast cancer among women treated with tibolone, accumulation of data obtained from radiological studies presents promising results. However, the safety of tibolone with regard to breast tissue needs to be investigated further, especially through well-designed, large-scale, randomised-controlled trials.<\/jats:p>","DOI":"10.1136\/pgmj.2005.037184","type":"journal-article","created":{"date-parts":[[2006,10,26]],"date-time":"2006-10-26T19:23:50Z","timestamp":1161890630000},"page":"658-662","source":"Crossref","is-referenced-by-count":7,"title":["Tibolone and breast cancer"],"prefix":"10.1093","volume":"82","author":[{"given":"C Tamer","family":"Erel","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Cerrahpasa School of Medicine, Istanbul University , Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent M","family":"Senturk","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Cerrahpasa School of Medicine, Istanbul University , Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semih","family":"Kaleli","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Cerrahpasa School of Medicine, Istanbul University , Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,10,26]]},"reference":[{"key":"2023042408035965500_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-5122(00)00184-5","article-title":"Tibolone. What does tissue specific activity mean?","volume":"37","author":"Palacios","year":"2001","journal-title":"Maturitas"},{"key":"2023042408035965500_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0960-0760(01)00044-9","article-title":"Tibolone: a steroid with a tissue-specific mode of action","volume":"76","author":"Kloosterboer","year":"2001","journal-title":"Steroid Biochem Mol Biol"},{"key":"2023042408035965500_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0960-0760(93)90003-F","article-title":"Human endometrial 3\u03b1-hydroxysteroid dehydrogenase\/isomerase can locally reduce intrinsic estrogenic\/progestagenic activity ratios of a steroidal drug (OrgOD14)","volume":"45","author":"Tang","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2023042408035965500_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0960-0760(94)90254-2","article-title":"Estrogenic and progestagenic activities coexisting in steroidal drugs: quantitative evaluation by in vitro bioassays with human cells","volume":"48","author":"Markiewicz","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2023042408035965500_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jcem.87.1.8141","article-title":"Tibolone for postmenopausal women: systematic review of randomized trial","volume":"87","author":"Modelska","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2023042408035965500_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jsbmb.2005.02.007","article-title":"Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer","volume":"93","author":"Pasqualini","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2023042408035965500_bib7","first-page":"135","article-title":"Effect of tibolone (Org OD14) and its metabolites on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells","volume":"17","author":"Cherite","year":"1997","journal-title":"Anticancer Res"},{"issue":"Suppl 167","key":"2023042408035965500_bib8","first-page":"35","article-title":"Estrone sulfatase and 17\u03b2-hydroxysteroid dehydrogenase activities in human breast cancer. Inhibitory effect by tibolone and its metabolites","volume":"76","author":"Pasqualini","year":"1997","journal-title":"Acta Obstet Gynaecol Scand"},{"key":"2023042408035965500_bib9","first-page":"269","article-title":"Effect of Org OD14 (Livial\u00ae) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T- 47D, and the hormone independent MDA-MB-231, breast cancer cells lines","volume":"19","author":"Chetrite","year":"1999","journal-title":"Anticancer Res"},{"key":"2023042408035965500_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0015-0282(02)03203-X","article-title":"In vitro studies of tibolone in breast cells","volume":"78","author":"Gompel","year":"2002","journal-title":"Fertil Steril"},{"key":"2023042408035965500_bib11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.fertnstert.2005.01.129","article-title":"Effect of 17\u03b2-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells","volume":"84","author":"Mirkin","year":"2005","journal-title":"Fertil Steril"},{"key":"2023042408035965500_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0039-128X(02)00184-8","article-title":"Tibolone is not converted by human aromatase to 7\u03b1-methyl-17\u03b1-ethynylestradiol (7\u03b1-MEE): analyses with sensitive bioassays for estrogens and androgens and with LC\u2013MS\/MS","volume":"68","author":"Gooyer","year":"2003","journal-title":"Steroids"},{"key":"2023042408035965500_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0960-0760(02)00068-7","article-title":"Effect of tibolone (Org OD14) and its metabolites on aromatase and estrone sulfatase activity in human breast adipose stromal cells and in MCF-7 and T47D breast cancer cells","volume":"81","author":"van","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2023042408035965500_bib14","first-page":"127","article-title":"Tibolone versus 17beta-estradiol\/norethisterone: effects on the proliferation of human breast cancer cells","volume":"23","author":"Lippert","year":"2002","journal-title":"Eur J Gynaecol Oncol"},{"key":"2023042408035965500_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0960-0760(94)90273-9","article-title":"Effects of progestrogens and Org OD14 in in vitro and in vivo tumor models","volume":"49","author":"Kloosterboer","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2023042408035965500_bib16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.gme.0000172269.32573.34","article-title":"Hormonal environment in the induction of breast cancer in castrated rats using dimethylbenzanthracene: influence of the presence or absence of ovarian activity and of treatment with estradiol, tibolone, and raloxifene","volume":"12","author":"Callejo","year":"2005","journal-title":"Menopause"},{"key":"2023042408035965500_bib17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/00042192-200211000-00007","article-title":"Effects of tibolone and hormone replacement therapy on the breast of cynomolgus monkeys","volume":"9","author":"Cline","year":"2002","journal-title":"Menopause"},{"key":"2023042408035965500_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ajog.2004.11.056","article-title":"Expression of p53 and markers for apoptosis in breast tissue during long-term hormone therapy in cynomolgus monkeys","volume":"193","author":"Conner","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"2023042408035965500_bib19","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0009-9260(97)80053-0","article-title":"The effect of hormone replacement therapy on recall rate in the National Health Service Breast Screening Programme","volume":"52","author":"Litherland","year":"1997","journal-title":"Clin Radiol"},{"key":"2023042408035965500_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0009-9260(99)90555-X","article-title":"The effect of hormone replacement therapy on the sensitivity of screening mammograms","volume":"54","author":"Litherland","year":"1999","journal-title":"Clin Radiol"},{"key":"2023042408035965500_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00008469-200002000-00003","article-title":"Mammographic densities and the prevalence and incidence of histological types of benign breast disease","volume":"9","author":"Boyd","year":"2000","journal-title":"Eur J Cancer Prev"},{"key":"2023042408035965500_bib22","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.fertnstert.2003.07.041","article-title":"Effect of tibolone and continuous combined hormone replacement therapy on mammographic breast density and breast histochemical markers in postmenopausal women","volume":"81","author":"Valdivia","year":"2004","journal-title":"Fertil Steril"},{"key":"2023042408035965500_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/13697130310001651472","article-title":"A comparative study on breast cell proliferation during HRT effects of tibolone and continuous combined estrogen progestogen treatment","volume":"7","author":"Conner","year":"2004","journal-title":"Climacteric"},{"key":"2023042408035965500_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0378-5122(96)01034-1","article-title":"Mammographic changes in women on hormonal replacement therapy","volume":"25","author":"Erel","year":"1996","journal-title":"Maturitas"},{"key":"2023042408035965500_bib25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.7326\/0003-4819-130-4_Part_1-199902160-00003","article-title":"Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen\/Progestin Interventions (PEPI) Investigators","volume":"130","author":"Greendale","year":"1999","journal-title":"Ann Intern Med"},{"key":"2023042408035965500_bib26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0002-9378(99)70560-0","article-title":"Mammographic breast density during hormone replacement therapy: differences according to treatment","volume":"181","author":"Lundstrom","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"2023042408035965500_bib27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0015-0282(01)01935-5","article-title":"Mammographic density changes during different postmenopausal hormone replacement therapies","volume":"76","author":"Sendag","year":"2001","journal-title":"Fertil Steril"},{"key":"2023042408035965500_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0378-5122(01)00236-5","article-title":"Mammographic density increase in women receiving different hormone replacement regimens","volume":"40","author":"Erel","year":"2001","journal-title":"Maturitas"},{"key":"2023042408035965500_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/cmt.4.1.42.48","article-title":"Mammographic breast density during hormone replacement therapy: efects of continuous combination, unopposed transdermal and low-potency estrogen regimens","volume":"4","author":"Lundstrom","year":"2001","journal-title":"Climacteric"},{"key":"2023042408035965500_bib30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0015-0282(01)01967-7","article-title":"Effects of a short-term suspension of hormone replacement therapy on mammographic density","volume":"76","author":"Colacurci","year":"2001","journal-title":"Fertil Steril"},{"key":"2023042408035965500_bib31","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0015-0282(98)00051-X","article-title":"Mammographic changes in women receiving tibolone therapy","volume":"69","author":"Erel","year":"1998","journal-title":"Fertil Steril"},{"key":"2023042408035965500_bib32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0301-2115(98)00129-8","article-title":"Effects of tibolone on the breast","volume":"80","author":"Colacurci","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2023042408035965500_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0020-7292(99)00102-2","article-title":"Mammographic and ultrasonographic study of changes in the breast related to HRT","volume":"67","author":"Ozdemir","year":"1999","journal-title":"Int J Gynaecol Obstet"},{"key":"2023042408035965500_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-5122(01)00232-8","article-title":"Effects of different types of hormone replacement therapy on mammographic density","volume":"40","author":"Colacurci","year":"2001","journal-title":"Maturitas"},{"key":"2023042408035965500_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-5122(01)00235-3","article-title":"A pilot study of hormone replacement therapy with tibolone in women with mastopathic breasts","volume":"40","author":"Egarter","year":"2001","journal-title":"Maturitas"},{"key":"2023042408035965500_bib36","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1067\/mob.2002.121896","article-title":"Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density","volume":"186","author":"Lundstrom","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"2023042408035965500_bib37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00042192-200203000-00005","article-title":"Mammographic changes associated with raloxifene and tibolone therapy in postmenopausal women: a prospective study","volume":"9","author":"Christodoulakos","year":"2002","journal-title":"Menopause"},{"key":"2023042408035965500_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00404-002-0306-7","article-title":"Effects of hormone replacement therapy on mammographic findings","volume":"268","author":"Bulbul","year":"2003","journal-title":"Arch Gynecol Obstet"},{"key":"2023042408035965500_bib39","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.fertnstert.2004.03.063","article-title":"Long-term effects of tibolone on mammographic density","volume":"82","author":"Bruce","year":"2004","journal-title":"Fertil Steril"},{"key":"2023042408035965500_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.maturitas.2005.02.010","article-title":"Postmenopausal hormone therapy and mammographic breast density","volume":"53","author":"Marchesoni","year":"2006","journal-title":"Maturitas"},{"key":"2023042408035965500_bib41","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/cmt.6.2.146.150","article-title":"Hormone replacement therapy in postmenopausal women with benign fibrocystic mastopathy","volume":"6","author":"Yenen","year":"2003","journal-title":"Climacteric"},{"key":"2023042408035965500_bib42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Million Women Study Collaborators","year":"2003","journal-title":"Lancet"},{"key":"2023042408035965500_bib43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/13697130410001713724","article-title":"Clinical background of women prescribed tibolone or combined estrogen + progestogen therapies: a UK MediPlus study","volume":"7","author":"Wierik","year":"2004","journal-title":"Climacteric"},{"key":"2023042408035965500_bib44","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ijc.20016","article-title":"Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe","volume":"109","author":"Stahlberg","year":"2004","journal-title":"Int J Cancer"},{"key":"2023042408035965500_bib45","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1471-0528.2004.00309.x","article-title":"The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial","volume":"112","author":"Kroiss","year":"2005","journal-title":"BJOG"},{"key":"2023042408035965500_bib46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial","volume":"288","author":"Writing Group for the WHI Investigators","year":"2002","journal-title":"JAMA"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/82\/972\/658\/50024770\/postgradmedj-82-658.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/82\/972\/658\/50024770\/postgradmedj-82-658.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T08:10:23Z","timestamp":1682323823000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/82\/972\/658\/7045322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,1]]},"references-count":46,"journal-issue":{"issue":"972","published-online":{"date-parts":[[2006,10,26]]},"published-print":{"date-parts":[[2006,10,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2005.037184","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2006,10]]},"published":{"date-parts":[[2006,10,1]]}}}